Aggrenox, a new aspirin and dipyridamole combination
January 2000
Boehringer Ingelheim is now introducing Aggrenox, a new aspirin and dipyridamole combination...to prevent stroke in patients who have already had an ischemic stroke or TIA.
Dipyridamole fell out of favor years ago because there wasn't enough evidence to show that it was effective.
But now there's convincing evidence that Aggrenox is MORE effective than aspirin alone to prevent recurrent stroke.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote